Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Invictus MD Strategies Corp. (V:GENE)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for GENE within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Feb 14, 2020 09:20 ET
IIROC Trading Resumption - GENE
VANCOUVER, Feb. 14, 2020 /CNW/ - Trading resumes in:
Read full article
Feb 13, 2020 15:55 ET
INVICTUS GRANTED CREDITOR PROTECTION AND WILL COMMENCE A STRATEGIC REVIEW
Invictus MD Strategies Corp. (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) (the “Company”) announced that on Thursday, February 13, 2020, the Supreme Court of British Columbia (the “Court”) issued an order granting the Company’s application for creditor...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
2.38
--
--
Price to Sales - TTM
1.50
11.84
10.56
Price to Book - most recent quarter
0.07
1.37
2.07
Price to Cash Flow per share - TTM
--
4.82
12.29
Price to Free Cash Flow per share - TTM
--
1.40
18.54
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Jan 31, 202014,9571,821
Jan 15, 202013,136-28,578
Dec 31, 201941,714-54,490
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Invictus MD Strategies Corp is Canada-based company engaged in the field of alternative medicine. The Company is focused on two main verticals within the Canadian cannabis sector: Licensed Producers and AB Laboratories Inc. The Licensed Producers vertical, which is under the Access to Cannabis for Medical Purposes (ACMPR), comprises investment in Acreage Pharms Ltd, located in West-Central Alberta; AB Laboratories Inc vertical comprises investment in AB Laboratories Inc, located near Hamilton, Ontario, which has both its cultivation and sales license under ACMPR.

See business summary

Twitter

Search (past week) for $GENE.CA GENE.V